[Sermion in the treatment of patients with neurological diseases].
Kovalenko
P A
PA
Kolomoets
Iu V
IuV
Seropegin
A D
AD
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D006801:Humans; D009530:Nicergoline / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013607:Tablets; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D013607:Tablets; D014665:Vasodilator Agents; D009530:Nicergoline